Competing in the rapidly-moving stem cell marketplace is a difficult task. You must analyze market conditions, predict industry trends, and capitalize on market changes before the competition. Especially within the rapidly evolving stem cell marketplace, it can be difficult to make educated, informed decisions that will drive revenue growth for your company, while limiting failed products that will not have demand in the marketplace.
Within an ever-changing marketplace, individuals who commit to understanding current opportunities and threats are positioned for a substantial strategic advantage.
Some stem cell companies and cord blood banks will make expensive new hires or a maintain business development departments in an effort to compete, but you don’t need to.
Small Levers Create Big Results
For a much smaller investment, you can immediately make informed, educated decisions about your marketplace. Market intelligence is your small “lever” that can create big results, because it will inform you about your environment from a 10,000 foot arial perspective.
When you are operating every day, you are living within a small micro-environment: your company. Therefore, you can’t easily see all of the changes and shifts that are talking place in the larger macro-environment in which you operate: your marketplace.
Are you truly able to track all the shifting collaborations and alliances, as well as the severed alliances that may have broken down? Do you really know all of the industry mergers and acquisitions that have occurred, and have you identified those which are now underway? Do you know of the industry trends that are taking shape, slowing at first, and then like a giant snowball, gathering power and momentum as they alter everything in their path? Do you know how consumer demands are shifting and what products your end-users are now seeking out? Do you know where funding is flowing from and have you identified those who have it?
“Competitive intelligence” have been given this name, because positions you to out-think your competition and it increases intelligence about your marketplace.
Are you using leveraged decision-making to acquire huge, massive results for your company?
Want to be better informed than your competition? Get future stem cell industry updates.
About Us
BioInformant is the only research firm that has served the stem cell sector since it emerged. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.
